¼¼°èÀÇ ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ½ÃÀå
Cardiovascular Information Systems
»óǰÄÚµå : 1650922
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ¼¼°è ½ÃÀå, 2030³â±îÁö 20¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 14¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 20¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ À¥ ±â¹Ý ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ºÎ¹®Àº CAGR 5.8%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 14¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 3¾ï 9,470¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.8%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ½ÃÀåÀº 2024³â 3¾ï 9,470¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È 5.8%ÀÇ CAGR·Î 2030³â±îÁö 3¾ï 1,940¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 5.5%¿Í 4.9%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛÀ̶õ ¹«¾ùÀ̸ç, ¿Ö ÇʼöÀûÀΰ¡?

½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ(CVIS)Àº ½ÉÇ÷°ü °Ç°­°ü¸®ÀÇ Çö´ëÈ­¿¡ ÇʼöÀûÀ̸ç, ½ÉÇ÷°ü µ¥ÀÌÅ͸¦ ¼öÁý, °ü¸® ¹× ºÐ¼®ÇÒ ¼ö ÀÖ´Â Á¾ÇÕÀûÀÎ Ç÷§ÆûÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Áø´Ü ¿µ»ó, °Ë»ç °á°ú, ÀÓ»ó º¸°í¼­, ½Ã¼ú µ¥ÀÌÅÍ µî ´Ù¾çÇÑ È¯ÀÚ Á¤º¸ ¼Ò½º¸¦ ÇϳªÀÇ Á¢±Ù °¡´ÉÇÑ ÀÎÅÍÆäÀ̽º·Î ÅëÇÕÇÕ´Ï´Ù. CVIS¸¦ ÅëÇØ ¼øÈ¯±â°ú Àü¹®ÀÇ, ¹æ»ç¼±»ç, °Ë»çÀÚ µî ÀÇ·áÁøÀº ¼øÈ¯±â ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ ÇÊ¿äÇÑ Á¤º¸¿¡ ½±°Ô Á¢±ÙÇÏ°í °øÀ¯ÇÒ ¼ö ÀÖÀ¸¸ç, ¹°¸®Àû ¼­·ù ÀÛ¼º°ú ¼öÀÛ¾÷ µ¥ÀÌÅÍ ÀÔ·ÂÀÇ Çʿ伺À» ÁÙ¿© º´¿ø°ú Ŭ¸®´ÐÀÇ ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. º´¿ø°ú Ŭ¸®´ÐÀÇ ¾÷¹« È帧À» °£¼ÒÈ­ÇÏ¿© ½ÉÇ÷°ü Áø´Ü ¹× Ä¡·á °èȹÀÇ Á¤È®¼º°ú ¼Óµµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. ½ÉÇ÷°üÁúȯÀÌ Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎ Áß ÇϳªÀÎ »óȲ¿¡¼­ Áß¿äÇÑ È¯ÀÚ µ¥ÀÌÅ͸¦ Á¤¸®Çϰí Á¦½ÃÇÏ´Â CVISÀÇ ¿ªÇÒÀº ÀÇ·á ȯ°æ¿¡¼­ ȯÀÚ °á°ú¿Í ¾÷¹« È¿À²¼ºÀ» °³¼±ÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, CVISÀÇ ÁøÁ¤ÇÑ °¡Ä¡´Â ½ÉÃÊÀ½ÆÄ, ½ÉÀüµµ(ECG), Ç÷°üÁ¶¿µ¼ú, ½ºÆ®·¹½º °Ë»ç µî ´Ù¾çÇÑ ½ÉÇ÷°ü °Ë»ç µ¥ÀÌÅ͸¦ ÅëÇÕÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ´Ù´Â µ¥ ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü °Ë»ç µ¥ÀÌÅ͸¦ ÅëÇÕÇÏ¿© °ü¸®ÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡ ÀÖ½À´Ï´Ù. CVIS´Â ´Ù¾çÇÑ Á¾·ùÀÇ ½ÉÇ÷°ü µ¥ÀÌÅ͸¦ ´ÜÀÏ Ç÷§Æû¿¡ ÅëÇÕÇÏ¿© ´ÜÆíÀûÀÎ ½ÉÇ÷°ü µ¥ÀÌÅ͸¦ ÅëÇÕÇÔÀ¸·Î½á, ÀÇ·á Àü¹®°¡µéÀÌ Ä¡·á °èȹ¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ´ÜÆíÀûÀÎ µ¥ÀÌÅÍ·Î ÀÎÇÑ ºñÈ¿À²¼ºÀ» ¾ø¾Ö°í, ¼­·Î ´Ù¸¥ ÀÇ·á ºÎ¼­ °£ÀÇ Çù¾÷À» °­È­ÇÕ´Ï´Ù.

±â¼úÀº ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛÀ» ¾î¶»°Ô º¯È­½ÃÄ״°¡?

±â¼úÀÇ ¹ßÀüÀ¸·Î ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛÀÇ ±â´ÉÀÌ Å©°Ô È®ÀåµÇ¾î ÀÇ·áÁø¿¡°Ô ´õ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °¡Àå Çõ½ÅÀûÀÎ ¹ßÀü Áß Çϳª´Â CVIS¿Í º´¿ø ÀüüÀÇ ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ÅëÇÕÀÔ´Ï´Ù. ÀÌ ÅëÇÕÀ» ÅëÇØ ¼öÀÛ¾÷À¸·Î ÀÎÇÑ µ¥ÀÌÅÍ ÀÔ·Â ¿À·ù¸¦ ÃÖ¼ÒÈ­Çϰí, ȯÀÚ ±â·ÏÀÇ ºÒ¿ÏÀü¼º ¹× Á¢±Ù¼º ºÎÁ·À¸·Î ÀÎÇÑ ¿ÀÁø À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇöÀç CVIS¿¡´Â ÀÓ»óÀǰ¡ ´ë±Ô¸ð µ¥ÀÌÅͼ¼Æ®¸¦ ½Å¼ÓÇÏ°Ô ºÐ¼®ÇÏ¿© ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ´Â °í±Þ µ¥ÀÌÅÍ ºÐ¼® µµ±¸°¡ žÀçµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸¿¡´Â ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÌ ³»ÀåµÇ¾î ÀÖ¾î, Àΰ£ÀÇ ºÐ¼®¸¸À¸·Î´Â ³õÄ¥ ¼ö ÀÖ´Â ½ÉÇ÷°ü µ¥ÀÌÅÍÀÇ ¹Ì¹¦ÇÑ ÆÐÅÏÀ» °¨ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, AI´Â ½ÉÀå ºÎÀÛ¿ëÀÇ °¡´É¼ºÀ» ¿¹ÃøÇÒ ¼ö ÀÖ¾î ¿¹¹æ Á¶Ä¡¸¦ º¸´Ù È¿°úÀûÀ¸·Î ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃֽŠCVIS Ç÷§ÆûÀº Ŭ¶ó¿ìµå ±â¼úÀ» äÅÃÇÏ¿© ½ÉÇ÷°ü µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¾ÈÀüÇÑ ¿ø°Ý ¾×¼¼½º¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ´Â COVID-19 »çŸ¦ °è±â·Î È®»êµÇ°í ÀÖ´Â ¿ø°ÝÀÇ·á¿Í ¿ø°ÝÁø·á¸¦ ÃËÁøÇÏ´Â µ¥ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ÀÇ»çµéÀº ÀÌÁ¦ ¾îµð¼­µç ½ÉÇ÷°ü µ¥ÀÌÅÍ¿Í Áø´Ü °á°ú¿¡ Á¢±ÙÇÒ ¼ö Àֱ⠶§¹®¿¡ ƯÈ÷ Áö¹æÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ È¯Àڵ鿡°Ô º¸´Ù À¯¿¬ÇÑ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¸ð¹ÙÀÏ Çコ(¸ð¹ÙÀÏ Çコ) ¼Ö·ç¼ÇÀÇ µîÀåÀº CVISÀÇ ¹ü¿ë¼ºÀ» ´õ¿í Çâ»ó½ÃÄ×½À´Ï´Ù. ÀÇ»ç´Â µ¥ÀÌÅ͸¦ ½Ã½ºÅÛ¿¡ Á÷Á¢ µ¿±âÈ­ÇÏ´Â ¿þ¾î·¯ºí ±â±â¸¦ ÅëÇØ ȯÀÚÀÇ ½ÉÀå »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ½ÉÇ÷°ü Ä¡·áÀÇ Á¤È®¼º°ú Àû½Ã¼ºÀ» ³ô¿´À» »Ó¸¸ ¾Æ´Ï¶ó, ½Ç½Ã°£ µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ ¸ÂÃãÇü Ä¡·á °èȹÀÌ °¡´ÉÇØÁ® º¸´Ù °³ÀÎÈ­µÈ Ä¡·á°¡ °¡´ÉÇØÁ³½À´Ï´Ù.

½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛÀÇ »õ·Î¿î Æ®·»µå´Â?

´õ ³ªÀº ȯÀÚ °á°ú¿¡ ´ëÇÑ ¿ä±¸¿Í µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤¿¡ ´ëÇÑ ÇコÄÉ¾î »ê¾÷ÀÇ º¯È­·Î ÀÎÇØ ½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ´Â ¸î °¡Áö »õ·Î¿î Æ®·»µå°¡ ÀÖ½À´Ï´Ù. Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â Áø´Ü Á¤È®µµ¿Í ¿¹Ãø ºÐ¼®À» Çâ»ó½Ã۱â À§ÇØ CVIS ³»¿¡¼­ AI¿Í ¸Ó½Å·¯´×ÀÇ È°¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¹æ´ëÇÑ ¾çÀÇ ½ÉÇ÷°ü µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ½ÉÀå ÁúȯÀÇ Ãʱ⠴ܰ踦 ³ªÅ¸³»´Â ÆÐÅÏÀ» ½Äº°ÇÔÀ¸·Î½á Àû½Ã¿¡ °³ÀÔÇÏ¿© ½É°¢ÇÑ ÇÕº´ÁõÀÇ °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ±â¹Ý CVIS ½Ã½ºÅÛÀº ½ºÄÉÁÙ¸µ, û±¸, º¸°í¿Í °°Àº °ü¸® ¾÷¹«¸¦ ÀÚµ¿È­ÇÏ¿© ÀÇ·áÁøÀÌ È¯ÀÚ Áø·á¿¡ ÁýÁßÇÒ ¼ö ÀÖ´Â ½Ã°£À» ´Ã¸®°í, CVIS Ç÷§ÆûÀÌ ´Ù¸¥ ÀÇ·á Á¤º¸ ½Ã½ºÅÛ°ú ¿øÈ°ÇÏ°Ô ¿¬°áµÊÀ¸·Î½á ȯÀÚÀÇ Àü¹ÝÀûÀÎ °Ç°­ »óŸ¦ ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ȯÀÚÀÇ Àü¹ÝÀûÀÎ °Ç°­ »óŸ¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼öÁØÀÇ ÅëÇÕÀº ¿©·¯ Áø·á°ú¿Í Àü¹®Àǰ¡ ȯÀÚ Ä¡·á¿¡ °ü¿©ÇÏ´Â ´ë±Ô¸ð ÀÇ·á ³×Æ®¿öÅ©¿Í º´¿ø ½Ã½ºÅÛ¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. »óÈ£¿î¿ë¼ºÀ» ÅëÇØ ½ÉÇ÷°ü µ¥ÀÌÅÍ´Â »çÀÏ·ÎÈ­µÇÁö ¾Ê°í ´õ Å« ±Ô¸ðÀÇ »óÈ£¿¬°áµÈ ½Ã½ºÅÛÀÇ ÀϺΰ¡ µÇ¾î ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¿ø°Ý ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½º¸¶Æ®¿öÄ¡³ª ÈÞ´ë¿ë ½ÉÀüµµ ¸ð´ÏÅÍ¿Í °°Àº ¿þ¾î·¯ºí ±â±â·ÎºÎÅÍÀÇ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Áö¿øÇÏ´Â CVIS Ç÷§ÆûÀÇ °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¼øÈ¯±â Àü¹®ÀÇ´Â ÀÓ»ó ȯ°æ ¹Û¿¡¼­ ȯÀÚÀÇ ½ÉÀå °Ç°­ »óŸ¦ ÃßÀûÇÒ ¼ö ÀÖÀ¸¸ç, ½ÉÀ帶ºñ³ª ºÎÁ¤¸ÆÀÇ À§ÇèÀÌ Àִ ȯÀÚ¿¡°Ô Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀÇ·áºñ Àý°¨°ú ȯÀÚ °á°ú °³¼±¿¡ ÁßÁ¡À» µÐ °¡Ä¡ ±â¹Ý Áø·á·ÎÀÇ ÀüȯÀº º´¿øÀÌ CVIS¸¦ µµÀÔÇÏ¿© ¾÷¹«¸¦ ÃÖÀûÈ­Çϰí, Áߺ¹À» ÁÙÀ̸ç, Àû½Ã¿¡ ±Ù°Å¿¡ ±â¹ÝÇÑ Áø·á¸¦ º¸ÀåÇϱâ À§ÇØ CVIS¸¦ µµÀÔÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå ¿äÀÎÀº?

½ÉÇ÷°ü Á¤º¸ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÇ·á °üÇàÀÇ º¯È­, ȯÀÚ ´ÏÁîÀÇ ÁøÈ­¿Í Á÷°áµÇ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â Àü ¼¼°è »ç¸Á ¿øÀÎ 1À§ÀÎ ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ½ÉÀå Áúȯ ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áø´Ü °Ë»ç, ¿µ»ó Áø´Ü, ȯÀÚ ¸ð´ÏÅ͸µ¿¡¼­ »ý¼ºµÇ´Â ´ë·®ÀÇ ½ÉÇ÷°ü µ¥ÀÌÅ͸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀÎ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí, Áß¿äÇÑ µ¥ÀÌÅÍ¿¡ ½±°Ô Á¢±ÙÇÏ¿© Àû½Ã¿¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ Ä¡·á °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï CVIS Ç÷§Æû¿¡ Á¡Á¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¶Ç ´Ù¸¥ ¿äÀÎÀº CVIS¿¡ AI¿Í ¿¹Ãø ºÐ¼® µµ±¸°¡ ÅëÇÕµÇ¾î º¸´Ù Á¤È®ÇÏ°í »çÀü ¿¹¹æÀûÀÎ Ä¡·á°¡ °¡´ÉÇØÁ³´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü µµ±¸¸¦ ÅëÇØ ÀÇ·á Àü¹®°¡´Â ÀáÀçÀûÀÎ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí, ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí, ºñ¿ëÀÌ ¸¹ÀÌ µå´Â º´¿ø ÀçÀÔ¿øÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀü°ú ´õºÒ¾î ¸ÂÃãÇü ÀÇ·á ¹× ¿ø°ÝÀÇ·á·ÎÀÇ Àüȯµµ CVIS ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº Á¡Á¡ ´õ ¸ÂÃãÈ­µÈ ÀÇ·á °æÇèÀ» ±â´ëÇÏ°Ô µÇ¾ú°í, CVIS Ç÷§ÆûÀº ÀÇ·á Á¦°øÀÚ°¡ °³º° ½ÉÇ÷°ü µ¥ÀÌÅ͸¦ ±â¹ÝÀ¸·Î Ä¡·á °èȹÀ» ¸ÂÃãÈ­ÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ ºÎ»óÀ¸·Î ¿ø°ÝÁø·á¿Í ½Ç½Ã°£ ȯÀÚ ¸ð´ÏÅ͸µÀ» Áö¿øÇϴ Ŭ¶ó¿ìµå ±â¹Ý CVIS Ç÷§ÆûÀÇ Çʿ伺ÀÌ ´õ¿í ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ±â°üÀº »óÈ£ ¿î¿ë¼ºÀ» ¿ì¼±½ÃÇϸç, ±âÁ¸ EHR ¹× ±âŸ ÀÓ»ó ¾ÖÇø®ÄÉÀ̼ǰú ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â CVIS ½Ã½ºÅÛÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ÷°ýÀûÀÌ°í »óÈ£ ¿î¿ë °¡´ÉÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸´Â º¸´Ù ¿¬°áµÇ°í È¿À²ÀûÀÎ ÀÇ·á »ýŰ踦 °¡´ÉÇÏ°Ô ÇÏ´Â CVISÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í °¡Ä¡ ±â¹Ý ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ CVISÀÇ Ã¤Å÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ǰÁú º¥Ä¡¸¶Å©¸¦ ÃæÁ·ÇÏ°í ½ÉÇ÷°ü Ä¡·áÀÇ ºñ¿ë È¿À²¼ºÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®ÀÔ´Ï´Ù.

ºÎ¹®

¿î¿µ ÇüÅÂ(À¥ ±â¹Ý, Ŭ¶ó¿ìµå, ¿Â»çÀÌÆ®), ¿ëµµ(Ä«Å×ÅÍ °Ë»ç½Ç CVIS ¼Ö·ç¼Ç, ½ÉÀüµµ, Àü±â»ý¸®ÇÐ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø, Áø´Ü¼¾ÅÍ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÁÖ¸ñ 44°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiovascular Information Systems Market to Reach US$2.0 Billion by 2030

The global market for Cardiovascular Information Systems estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Web-based Cardiovascular Information Systems, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Cloud-based Cardiovascular Information Systems segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$394.7 Million While China is Forecast to Grow at 5.8% CAGR

The Cardiovascular Information Systems market in the U.S. is estimated at US$394.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$319.4 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Cardiovascular Information Systems Market - Key Trends and Drivers Summarized

What Are Cardiovascular Information Systems and Why Are They Indispensable?

Cardiovascular Information Systems (CVIS) are critical to the modernization of cardiovascular healthcare, providing a comprehensive platform for collecting, managing, and analyzing cardiovascular data. These systems integrate various sources of patient information, such as diagnostic images, test results, clinical reports, and procedural data, into one accessible interface. This allows healthcare providers, including cardiologists, radiologists, and technicians, to easily access and share information necessary for diagnosing and treating cardiovascular conditions. CVIS also streamlines workflows in hospitals and clinics by reducing the need for physical paperwork and manual data entry, which in turn enhances the accuracy and speed of cardiovascular diagnostics and care planning. In an era where cardiovascular diseases are one of the leading causes of death globally, the role of CVIS in organizing and presenting critical patient data is indispensable for improving patient outcomes and operational efficiency in healthcare settings. The real value of CVIS lies in its ability to integrate and manage data from a wide array of cardiovascular tests, including echocardiograms, electrocardiograms (ECGs), angiograms, and stress tests. These systems provide healthcare professionals with immediate access to both real-time and historical patient data, ensuring that they can make informed, data-driven decisions regarding treatment plans. By consolidating disparate types of cardiovascular data into a single platform, CVIS eliminates inefficiencies caused by fragmented data and enhances the collaboration among different medical departments.

How Has Technology Transformed Cardiovascular Information Systems?

Advances in technology have significantly expanded the capabilities of Cardiovascular Information Systems, enhancing their functionality and making them more user-friendly for healthcare professionals. One of the most transformative developments has been the integration of CVIS with hospital-wide Electronic Health Records (EHR), allowing cardiovascular data to be easily shared across departments, ensuring a seamless flow of patient information. This integration minimizes errors caused by manual data entry and reduces the risk of misdiagnosis due to incomplete or inaccessible patient records. Moreover, CVIS now includes advanced data analytics tools, which enable clinicians to quickly analyze large datasets and extract actionable insights. These tools often incorporate artificial intelligence (AI) and machine learning algorithms, which can detect subtle patterns in cardiovascular data that might be missed by human analysis alone. For instance, AI can predict the likelihood of adverse cardiac events, allowing for preventive measures to be implemented more effectively. Furthermore, modern CVIS platforms have embraced cloud technology, allowing for secure, remote access to cardiovascular data. This is particularly useful in facilitating telemedicine and remote consultations, which have become more prevalent in the wake of the COVID-19 pandemic. Physicians can now access cardiovascular data and diagnostic results from any location, enabling more flexible care delivery, especially for patients in rural or underserved areas. The rise of mobile health (mHealth) solutions has further improved the versatility of CVIS, as doctors can monitor patients’ heart conditions in real-time through wearable devices that sync data directly into the system. These technological innovations have not only enhanced the accuracy and timeliness of cardiovascular care but also made it more personalized, allowing for tailored treatment plans based on real-time data.

What Are the Emerging Trends in Cardiovascular Information Systems?

Several emerging trends are shaping the future of Cardiovascular Information Systems, driven by the need for better patient outcomes and the healthcare industry's shift toward data-driven decision-making. One of the key trends is the increasing use of AI and machine learning within CVIS to improve diagnostic accuracy and predictive analytics. These technologies can analyze vast amounts of cardiovascular data and identify patterns that might indicate the early stages of heart disease, allowing for timely interventions and reducing the likelihood of severe complications. Additionally, AI-powered CVIS systems can help in automating administrative tasks such as scheduling, billing, and reporting, freeing up more time for healthcare providers to focus on patient care. Another trend is the rise of interoperable systems, where CVIS platforms can seamlessly connect with other healthcare information systems, enabling a holistic view of the patient’s overall health. This level of integration is particularly important in large healthcare networks and hospital systems, where multiple departments and specialists are involved in a patient’s care. Interoperability ensures that cardiovascular data is not siloed but rather is part of a larger, interconnected system that improves clinical decision-making. Additionally, the growing demand for remote patient monitoring has fueled the development of CVIS platforms that support real-time data from wearable devices such as smartwatches and portable ECG monitors. This allows cardiologists to track the heart health of their patients outside the clinical environment, providing continuous monitoring for those at risk of heart attacks or arrhythmias. Lastly, the shift toward value-based care, where the emphasis is on improving patient outcomes while reducing healthcare costs, has encouraged hospitals to adopt CVIS to optimize their operations, reduce redundancies, and ensure that care is timely and evidence-based.

What Are the Factors Behind the Growth of the Cardiovascular Information Systems Market?

The growth in the Cardiovascular Information Systems market is driven by several factors directly linked to advancements in technology, changing healthcare practices, and evolving patient needs. One of the key drivers is the increasing prevalence of cardiovascular diseases, which are the leading cause of death worldwide. As the number of patients with heart conditions rises, so does the demand for efficient systems that can manage the large volumes of cardiovascular data generated from diagnostic tests, imaging, and patient monitoring. Healthcare providers are increasingly turning to CVIS platforms to streamline their workflows and ensure that critical data is readily accessible for making timely and informed treatment decisions. Another factor contributing to the market’s growth is the integration of AI and predictive analytics tools within CVIS, which allow for more precise and proactive care. These advanced tools enable healthcare professionals to detect potential issues early on, improving patient outcomes and reducing costly hospital readmissions. In addition to technological advancements, the shift toward personalized and remote care is also fueling the demand for CVIS systems. Patients are increasingly expecting more tailored healthcare experiences, and CVIS platforms help meet this demand by enabling healthcare providers to customize treatment plans based on individual cardiovascular data. The rise of telemedicine has further highlighted the need for cloud-based CVIS platforms that support remote consultations and real-time patient monitoring. Additionally, healthcare organizations are prioritizing interoperability, seeking CVIS systems that can seamlessly integrate with existing EHRs and other clinical applications. This need for comprehensive, interoperable solutions is driving the adoption of CVIS, as they enable a more connected and efficient healthcare ecosystem. Lastly, the increasing focus on regulatory compliance and the push for value-based care have led to higher adoption rates of CVIS, as these systems help healthcare providers meet quality benchmarks and improve the cost-effectiveness of cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Cardiovascular Information Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Mode of Operation (Web-Based, Cloud, Onsite); Application (Catheterization Lab CVIS Solutions, Electrocardiography, Electrocardiogram, Electrophysiology, Other Applications); End-Use (Hospitals, Diagnostic Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â